Remove 2006 Remove FDA Remove Vaccines
article thumbnail

Record number of health firms feature in UK top 100 private tech list

pharmaphorum

There are pharma companies on the list, including Kymab , which at number 87 is working with the Bill & Melinda Gates Foundation to test several potential vaccines. Seventy-seven firms on this year’s list were funded by venture capital or angel investors, compared with 41 in the first year.

article thumbnail

A history of AstraZeneca

pharmaphorum

In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide). In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2

Vaccines 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Merck defends blockbuster Januvia franchise from patent challenge

pharmaphorum

Viatris is seeking FDA approval to market generic versions of both Januvia and Janumet in the US. The two judgments are a big victory for Merck, given that Januvia remains its third best-selling product after cancer immunotherapy Keytruda (pembrolizumab) and HPV vaccine Gardasil, with sales of almost $2.5 The US patent (No.

article thumbnail

Biosimilars: a rapidly maturing market

pharmaphorum

The global health crisis caused spending on healthcare to increase , due to the funding provided to the development and purchases of vaccines and treatments, as well as support provided for the associated infrastructure. The short story so far.

article thumbnail

Methylprednisolone interactions to avoid

The Checkup by Singlecare

The interaction is severe enough that prescribing information for many NSAIDs warns against the concomitant use of corticosteroids in a Food and Drug Administration (FDA) issued Medication Guide. Still, they are independently associated with many significant side effects, much so that the FDA has issued guidance regarding their use.

article thumbnail

Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2003-2022)

PharmaShots

Its subsidiary, DePuy's CHARITE Artificial Disc for degenerative disc disease was the first device to be approved by the US FDA By acquiring Roche’s OTC business, Bayer was able to strengthen its consumer health business. by the sales of Humira 2006 Johnson & Johnson recorded global sales of $53.3B

article thumbnail

Top 20 Radiopharma Companies Based on Market Cap

PharmaShots

In Aug’21, the US FDA cleared QSam’s IND application for CycloSam. In Jun’21, the company initiated the evaluation of FAP-2286 in a P-I/II clinical trial (LuMIERE) following the US FDA’s IND clearance. In Sep’21, the US FDA granted DUNP19 an ODD for Osteosarcoma.

FDA 56